SCHEMBL10067503

SCHEMBL10067503

Cc1cc(N(CO)CCO)ccc1/N=N/c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 10/20 0.50
MEN1 O00255 9/20 0.50
MAPT P10636 8/20 0.50
ALDH1A1 P00352 6/20 0.50
NPC1 O15118 6/20 0.50
RAB9A P51151 6/20 0.50
POLB P06746 5/20 0.50
TDP1 Q9NUW8 4/20 0.50
MAPK1 P28482 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
LMNA P02545 2/20 0.50
MMP14 P50281 2/20 0.50
GAA P10253 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
NPSR1 Q6W5P4 2/20 0.46
HTT P42858 1/20 0.46
HSP90AA1 P07900 2/20 0.38
KDR P35968 1/20 0.38
RECQL P46063 1/20 0.38
TNNI3 P19429 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL112231 0.95 KMT2A (0.55) KMT2AMEN1MAPTALDH1A1NPC1
SCHEMBL112230 0.95 KMT2A (0.55) KMT2AMEN1MAPTALDH1A1NPC1
SCHEMBL29358253 0.95 KMT2A (0.55) KMT2AMEN1MAPTALDH1A1NPC1
SCHEMBL1627083 0.87 KMT2A (0.47) KMT2AMEN1MAPTALDH1A1NPC1
SCHEMBL25419671 0.87 KMT2A (0.47) KMT2AMEN1MAPTALDH1A1NPC1
SCHEMBL7717321 0.87 POLB (0.58) KMT2AMEN1MAPTALDH1A1NPC1
SCHEMBL1087160 0.86 MAPT (0.52) KMT2AMEN1MAPTALDH1A1NPC1
SCHEMBL14994403 0.86 KMT2A (0.46) KMT2AMEN1MAPTALDH1A1NPC1
SCHEMBL14994401 0.86 KMT2A (0.46) KMT2AMEN1MAPTALDH1A1NPC1
SCHEMBL30887106 0.86 KMT2A (0.46) KMT2AMEN1MAPTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9687057-B2 Dye composition using a specific non-ionic hydrotropic compound in a medium rich in fatty substances, methods and device L'OREAL (FR) 2017-06-27 US disclosed
US-9687057-B2 Dye composition using a specific non-ionic hydrotropic compound in a medium rich in fatty substances, methods and device L'OREAL (FR) 2017-06-27 US disclosed
US-9578944-B2 Compositions and methods for altering the appearance of hair L'OREAL (FR) 2017-02-28 US disclosed
US-9578944-B2 Compositions and methods for altering the appearance of hair L'OREAL (FR) 2017-02-28 US disclosed
US-9566221-B2 Methods for altering the color and appearance of hair L'OREAL (FR) 2017-02-14 US disclosed
US-9565915-B2 Compositions and methods for altering the appearance of hair L'OREAL (FR) 2017-02-14 US disclosed
US-9565916-B2 Compositions and methods for altering the appearance of hair L'OREAL (FR) 2017-02-14 US disclosed
US-9566221-B2 Methods for altering the color and appearance of hair L'OREAL (FR) 2017-02-14 US disclosed
US-9565916-B2 Compositions and methods for altering the appearance of hair L'OREAL (FR) 2017-02-14 US disclosed
US-9565915-B2 Compositions and methods for altering the appearance of hair L'OREAL (FR) 2017-02-14 US disclosed
US-20120204357-A1 COMPOSITION COMPRISING A HYDROPHOBIC DYE, A PARTICULAR ORGANIC AND/OR MINERAL ALKALINE AGENT, A PARTICULAR COMPOUND (I) AND A PARTICULAR ORGANIC COMPOUND (II), AND DYEING USE THEREOF L'OREAL (FR) 2012-08-16 US disclosed
WO-2012084820-A2 COMPOSITION COMPRISING A NATURAL DYE AND/OR A CATIONIC AND/OR NONIONIC DIRECT DYE, AND/OR A DYE PRECURSOR, AN INSOLUBLE SILICATE AND A MONO- OR POLYGLYCOSIDE L'OREAL (FR) 2012-06-28 WO disclosed
WO-2012084818-A2 HAIR DYEING PROCESS USING AN INSOLUBLE SILICATE, AN AROMATIC COMPOUND AND A HYDROXYLATED ALIPHATIC SOLVENT L'OREAL (FR) 2012-06-28 WO disclosed
EP-2359804-A2 Composition including an oxidation dye and a derivative of phosphonium or ammonium hydroxide, dyeing of keratin fibres and device L'Oréal (FR) 2011-08-24 EP disclosed
WO-2011027076-A2 DYEING METHOD CONSISTING IN APPLYING A METALLIC SALT AND A COMPOSITION CONTAINING A HYDROPHOBIC DYE AND A SPECIFIC COMPOUND L'OREAL (FR) 2011-03-10 WO disclosed
WO-2011027077-A2 COMPOSITION COMPRISING A HYDROPHOBIC DYE, A SPECIFIC MINERAL AND/OR ORGANIC ALKALINE AGENT, A SPECIFIC COMPOUND (I) AND A SPECIFIC ORGANIC COMPOUND (II), AND USE THEREOF IN DYEING L'OREAL (FR) 2011-03-10 WO disclosed
WO-2010097558-A2 COMPOSITION CONTAINING A NATURAL OR SYNTHETIC DYE AND AN ALIPHATIC MONOHYDROXYLATED ALCOHOL AND KERATIN FIBRE DYEING METHOD USING SAME L'OREAL (FR) 2010-09-02 WO disclosed
US-20090282624-A1 Composition comprising a hydrophobic dye and an alkylene carbonate or a lactone and dyeing of keratinous fibres L'OREAL S.A. (FR) 2009-11-19 US disclosed
US-20090282624-A1 Composition comprising a hydrophobic dye and an alkylene carbonate or a lactone and dyeing of keratinous fibres L'OREAL S.A. (FR) 2009-11-19 US disclosed
EP-2095809-A1 Composition comprising a hydrophobic colorant and an alkylene carbonate or a lactone and dyeing of keratinous fibres L'Oréal (FR) 2009-09-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120204357-A1 COMPOSITION COMPRISING A HYDROPHOBIC DYE, A PARTICULAR ORGANIC AND/OR MINERAL ALKALINE AGENT, A PARTICULAR COMPOUND (I) AND A PARTICULAR ORGANIC COMPOUND (II), AND DYEING USE THEREOF KRT18, DSG1, DSC1 KMT2A 1902/4885MEN1 1074/4885MAPT 331/4885
US-20090282624-A1 Composition comprising a hydrophobic dye and an alkylene carbonate or a lactone and dyeing of keratinous fibres KRT18, H1-0, H1-5 KMT2A 2300/4885MEN1 2019/4885MAPT 2082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.